Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Allakos Inc. - Common Stock
(NQ:
ALLK
)
0.3127
+0.0151 (+5.07%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,552,522
Open
0.2900
Bid (Size)
0.3002 (58)
Ask (Size)
0.3100 (2)
Prev. Close
0.2976
Today's Range
0.2770 - 0.3197
52wk Range
0.2280 - 1.690
Shares Outstanding
86,560,315
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
January 31, 2025
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on TikTok.
Via
Benzinga
On Friday, there are stocks with unusual volume. Let's take a look.
January 31, 2025
Unusual volume stocks are being observed in Friday's session.
Via
Chartmill
Performance
YTD
-74.78%
-74.78%
1 Month
-63.96%
-63.96%
3 Month
-73.04%
-73.04%
6 Month
-54.48%
-54.48%
1 Year
-75.38%
-75.38%
More News
Read More
The trading volume of these stocks is deviating from the norm in today's session.
January 29, 2025
Via
Chartmill
Get insights into the top gainers and losers of Tuesday's pre-market session.
January 28, 2025
Via
Chartmill
Why Is Allakos Stock Plunging On Monday?
January 27, 2025
Via
Benzinga
ALLK Stock Earnings: Allakos Beats EPS for Q2 2024
August 07, 2024
Via
InvestorPlace
Which stocks are experiencing notable movement on Monday?
January 27, 2025
Via
Chartmill
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade
January 27, 2025
Via
Stocktwits
S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher
January 27, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
These stocks are moving in today's session
January 27, 2025
Via
Chartmill
Dow Edges Higher; AT&T Posts Upbeat Earnings
January 27, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Traders are paying attention to the gapping stocks in Monday's session.
January 27, 2025
Via
Chartmill
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December
January 27, 2025
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
These stocks that are showing activity before the opening bell on Monday.
January 27, 2025
Via
Chartmill
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
January 27, 2025
From
Allakos Inc.
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 11, 2024
Via
Benzinga
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
October 10, 2024
From
Allakos Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 04, 2024
Via
Benzinga
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
August 07, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
June 25, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
May 28, 2024
From
Allakos Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.